Zhang Huaqiu, Yan Qin, Xu Shutian, Ou Yibo, Ye Fei, Wang Baofeng, Lei Ting, Guo Dongsheng
Department of Neurosurgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
J Huazhong Univ Sci Technolog Med Sci. 2011 Aug;31(4):520. doi: 10.1007/s11596-011-0483-3. Epub 2011 Aug 7.
The Leucine-rich repeats and immunoglobulin-like domains-2 (LRIG2) gene expression in pituitary adenoma and its correlation with tumor invasiveness were studied. The expression of LRIG2 mRNA and protein in human pituitary adenoma obtained surgically was detected by RT-PCR (39 cases) and immunohistochemical staining (30 cases). It was found that LRIG2 was mostly localized at the nucleus of the pituitary adenoma cells. Its expression was significantly higher in the invasive cases than in the non-invasive cases. LRIG2 protein was positive in 14 cases out of 21 cases of invasive adenoma, but only 2 cases were positive in 9 cases of non-invasive adenoma. The positive expression rate of LRIG2 mRNA was 91.3% in invasive cases (total 23 cases) and 62.5% in non-invasive cases (total 16 cases), respectively. LRIG2 gene is overexpressed in invasive pituitary adenoma. It may play an important role in pituitary adenoma invasiveness and further studies are necessary to elucidate the mechanism under this phenomenon.
研究了富含亮氨酸重复序列和免疫球蛋白样结构域-2(LRIG2)基因在垂体腺瘤中的表达及其与肿瘤侵袭性的相关性。采用逆转录-聚合酶链反应(RT-PCR,39例)和免疫组织化学染色(30例)检测手术切除的人垂体腺瘤中LRIG2 mRNA和蛋白的表达。发现LRIG2主要定位于垂体腺瘤细胞的细胞核。其在侵袭性病例中的表达明显高于非侵袭性病例。21例侵袭性腺瘤中有14例LRIG2蛋白呈阳性,而9例非侵袭性腺瘤中仅2例呈阳性。LRIG2 mRNA在侵袭性病例(共23例)中的阳性表达率为91.3%,在非侵袭性病例(共16例)中的阳性表达率为62.5%。LRIG2基因在侵袭性垂体腺瘤中过表达。它可能在垂体腺瘤侵袭性中起重要作用,有必要进一步研究以阐明这种现象背后的机制。